Development and validation of a polysocial risk score for atherosclerotic cardiovascular disease

被引:38
|
作者
Javed, Zulqarnain [1 ]
Valero-Elizondo, Javier [2 ,3 ]
Dudum, Ramzi [4 ]
Khan, Safi U. [2 ]
Dubey, Prachi [5 ]
Hyder, Adnan A. [6 ]
Xu, Jiaqiong [2 ,7 ]
Bilal, Usama [8 ,9 ]
Kash, Bita A. [7 ,10 ,11 ]
Cainzos-Achirica, Miguel [1 ,2 ,3 ]
Nasir, Khurram [1 ,2 ,3 ]
机构
[1] Houston Methodist, Ctr Outcomes Res, Div Hlth Equ & Dispar Res, Houston, TX 77030 USA
[2] Methodist DeBakey Heart & Vasc Ctr, Dept Cardiol, Div Cardiovasc Prevent & Wellness, Houston, TX 77030 USA
[3] Houston Methodist, Ctr Cardiovasc Computat Hlth & Precis Med C3 PH, Houston, TX 77030 USA
[4] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA
[5] Houston Methodist Hosp, Houston Methodist Res Inst, Houston, TX 77030 USA
[6] Georgetown Washington Univ, Milken Inst Sch Publ Hlth, Washington, DC USA
[7] Houston Methodist, Ctr Outcomes Res, Houston, TX USA
[8] Drexel Dornsife Sch Publ Hlth, Urban Hlth Collaborat, Philadelphia, PA USA
[9] Drexel Dornsife Sch Publ Hlth, Dept Epidemiol & Biostat, Philadelphia, PA USA
[10] Weill Cornell Med, New York, NY USA
[11] Texas A&M Univ, Sch Rural Publ Hlth, College Stn, TX USA
关键词
ASCVD; Cardiovascular disease; Polysocial risk score; Social determinants of health; SOCIOECONOMIC-STATUS; SOCIAL DETERMINANTS; DEPRESSIVE SYMPTOMS; LIFE-COURSE; MORTALITY; HEALTH; IMPACT; POSITION; MIDDLE; MEN;
D O I
10.1016/j.ajpc.2021.100251
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To date, the extent to which social determinants of health (SDOH) may help identify individuals with atherosclerotic cardiovascular disease (ASCVD) - beyond traditional risk factors - has not been quantified using a cumulative social disadvantage approach. The objective of this study was to develop, and validate, a polysocial risk score (PsRS) for prevalent ASCVD in a nationally representative sample of adults in the United States (US). Methods: We used data from the 2013-2017 National Health Interview Survey. A total of 38 SDOH were identified from the database. Stepwise and criterion-based selection approaches were applied to derive PsRS, after adjusting for traditional risk factors. Logistic regression models were fitted to assign risk scores to individual SDOH, based on relative effect size magnitudes. PsRS was calculated by summing risk scores for individual SDOH, for each participant; and validated using a separate validation cohort. Results: Final sample comprised 164,696 adults. PsRS included 7 SDOH: unemployment, inability to pay medical bills, low income, psychological distress, delayed care due to lack of transport, food insecurity, and less than high school education. PsRS ranged from 0-20 and exhibited excellent calibration and discrimination. Individuals with the highest PsRS (5(th) quintile) had nearly 4-fold higher ASCVD prevalence, relative to those with the lowest risk scores (1(st) quintile). Area under receiver operating curve (AU-ROC) for PsRS with SDOH alone was 0.836. Addition of SDOH to the model with only demographic and clinical risk factors (AU-ROC= 0.852) improved overall discriminatory power, with AU-ROC for final PsRS (demographics + clinical + SDOH) = 0.862. Conclusions: Cumulatively, SDOH may help identify individuals with ASCVD, beyond traditional cardiovascular risk factors. In this study, we provide a unique validated PsRS for ASCVD in a national sample of US adults. Future study should target development of similar scores in diverse populations, and incorporate longitudinal study designs.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] DEVELOPMENT AND VALIDATION OF LONG-TERM RISK MODELS FOR PREDICTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD): THE CARDIOVASCULAR LIFETIME RISK POOLING PROJECT (LRPP)
    Guo, James W.
    Ning, Hongyan
    Khan, Sadiya Sana
    Wilkins, John
    Lloyd-Jones, Donald M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1672 - 1672
  • [22] Mortality Risk Detected by Atherosclerotic Cardiovascular Disease Score in Patients With Nonalcoholic Fatty Liver Disease
    Golabi, Pegah
    Fukui, Natsu
    Paik, James
    Sayiner, Mehmet
    Mishra, Alita
    Younossi, Zobair M.
    HEPATOLOGY COMMUNICATIONS, 2019, 3 (08) : 1050 - 1060
  • [23] A novel cardiovascular disease risk score for prediction of atherosclerotic disease events in men with prostate cancer
    Stabellini, Nickolas
    Tan, Min Choon
    Cullen, Jennifer
    Weintraub, Neal L.
    Shanahan, John
    Agarwal, Neeraj
    Patel, Sagar A.
    Montero, Alberto J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 314 - 314
  • [24] Performance of nonalcoholic fatty liver fibrosis score in estimating atherosclerotic cardiovascular disease risk
    Huang, Ya-Chin
    Huang, Jiun-Chi
    Chien, Hsu-Han
    Lin, Chia-, I
    Chuang, Yun-Shiuan
    Cheng, Han-Yun
    Lin, Wei-Ting
    Lin, Yu-Yin
    Chuang, Hung-Yi
    Wang, Chao-Ling
    Dai, Chia-Yen
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2023, 33 (12) : 2479 - 2487
  • [25] Association between a cardiovascular risk score and early markers of atherosclerotic disease in Chilean children
    Arnaiz, Pilar
    Pino, Felipe
    Marin, Arnaldo
    Barja, Salesa
    Aglony, Marlene
    Cassis, Berta
    Navarrete, Carlos
    Acevedo, Monica
    REVISTA MEDICA DE CHILE, 2010, 138 (10) : 1226 - 1231
  • [26] Metabolomics profile and 10-year atherosclerotic cardiovascular disease (ASCVD) risk score
    Dehghanbanadaki, Hojat
    Dodangeh, Salimeh
    Roudsari, Peyvand Parhizkar
    Hosseinkhani, Shaghayegh
    Khashayar, Pouria
    Noorchenarboo, Mohammad
    Rezaei, Negar
    Dilmaghani-Marand, Arezou
    Yoosefi, Moein
    Arjmand, Babak
    Khalagi, Kazem
    Najjar, Niloufar
    Kakaei, Ardeshir
    Bandarian, Fatemeh
    Meybodi, Hamid Aghaei
    Larijani, Bagher
    Razi, Farideh
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [27] Estimated Atherosclerotic Cardiovascular Disease Risk Score: An Automated Decision Aid for Statin Therapy
    Sampson, Maureen
    Wolska, Anna
    Amar, Marcelo
    Ueda, Masako
    Dunbar, Richard
    Soffer, Daniel
    Remaley, Alan T.
    CLINICAL CHEMISTRY, 2022, 68 (10) : 1302 - 1310
  • [28] Lipoprotein(a) Atherosclerotic Cardiovascular Disease Risk Score Development and Prediction in Primary Prevention From Real-World Data
    Fan, Wenjun
    Wu, Chuyue
    Wong, Nathan D.
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2025, 18 (01):
  • [29] Cardiovascular Health Score and Atherosclerotic Cardiovascular Disease in the Million Veteran Program
    Nguyen, Xuan-Mai T.
    Li, Yanping
    Gong, Yusi
    Houghton, Serena
    Ho, Yuk-Lam
    Pyatt, Mary
    Treu, Timothy
    Li, Ruifeng
    Akinosho, Kitan
    Raghavan, Sridharan
    Gagnon, David R.
    Gaziano, John Michael
    Wilson, Peter W. F.
    Cho, Kelly
    JAMA NETWORK OPEN, 2024, 7 (12)
  • [30] DEVELOPMENT AND CLINICAL VALIDATION OF A GENETIC RISK SCORE FOR COELIAC DISEASE
    Sharp, Seth
    Jones, Samuel
    Kimmitt, Robert
    Weedon, Michael
    Halpin, Anne
    Wood, Andrew
    King, Seema
    Beaumont, Robin
    Hagopian, William
    Turner, Justine
    Oram, Richard
    GUT, 2019, 68 : A162 - A162